These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 11511365)

  • 1. Integrin-specific activation of Rac controls progression through the G(1) phase of the cell cycle.
    Mettouchi A; Klein S; Guo W; Lopez-Lago M; Lemichez E; Westwick JK; Giancotti FG
    Mol Cell; 2001 Jul; 8(1):115-27. PubMed ID: 11511365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events.
    Schlaepfer DD; Jones KC; Hunter T
    Mol Cell Biol; 1998 May; 18(5):2571-85. PubMed ID: 9566877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of rho kinase and actin stress fibers on sustained extracellular signal-regulated kinase activity and activation of G(1) phase cyclin-dependent kinases.
    Roovers K; Assoian RK
    Mol Cell Biol; 2003 Jun; 23(12):4283-94. PubMed ID: 12773570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells.
    Bhatia N; Agarwal C; Agarwal R
    Nutr Cancer; 2001; 39(2):292-9. PubMed ID: 11759294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation.
    Mainiero F; Murgia C; Wary KK; Curatola AM; Pepe A; Blumemberg M; Westwick JK; Der CJ; Giancotti FG
    EMBO J; 1997 May; 16(9):2365-75. PubMed ID: 9171350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct roles of the adaptor protein Shc and focal adhesion kinase in integrin signaling to ERK.
    Barberis L; Wary KK; Fiucci G; Liu F; Hirsch E; Brancaccio M; Altruda F; Tarone G; Giancotti FG
    J Biol Chem; 2000 Nov; 275(47):36532-40. PubMed ID: 10976102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN.
    Gu J; Tamura M; Pankov R; Danen EH; Takino T; Matsumoto K; Yamada KM
    J Cell Biol; 1999 Jul; 146(2):389-403. PubMed ID: 10427092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anchorage-dependent regulation of the mitogen-activated protein kinase cascade by growth factors is supported by a variety of integrin alpha chains.
    Aplin AE; Short SM; Juliano RL
    J Biol Chem; 1999 Oct; 274(44):31223-8. PubMed ID: 10531317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways.
    Gu J; Tamura M; Yamada KM
    J Cell Biol; 1998 Nov; 143(5):1375-83. PubMed ID: 9832564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of fibronectin binding to the alpha 5 beta 1 integrin stimulates the expression of cyclin-dependent kinases and DNA synthesis through activation of extracellular signal-regulated kinase.
    Gong J; Ko TC; Brattain MG
    J Biol Chem; 1998 Jan; 273(3):1662-9. PubMed ID: 9430710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the G1 phase of the cell cycle.
    Oktay M; Wary KK; Dans M; Birge RB; Giancotti FG
    J Cell Biol; 1999 Jun; 145(7):1461-9. PubMed ID: 10385525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
    Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin activation and focal complex formation in cardiac hypertrophy.
    Laser M; Willey CD; Jiang W; Cooper G; Menick DR; Zile MR; Kuppuswamy D
    J Biol Chem; 2000 Nov; 275(45):35624-30. PubMed ID: 10958798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGF receptor mediates adhesion-dependent activation of the Rac GTPase: a role for phosphatidylinositol 3-kinase and Vav2.
    Marcoux N; Vuori K
    Oncogene; 2003 Sep; 22(38):6100-6. PubMed ID: 12955089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of MEK- and phosphoinositide 3-kinase-dependent signalling as essential events during Chlamydia pneumoniae invasion of HEp2 cells.
    Coombes BK; Mahony JB
    Cell Microbiol; 2002 Jul; 4(7):447-60. PubMed ID: 12102690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression.
    Wary KK; Mainiero F; Isakoff SJ; Marcantonio EE; Giancotti FG
    Cell; 1996 Nov; 87(4):733-43. PubMed ID: 8929541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RACK1 regulates G1/S progression by suppressing Src kinase activity.
    Mamidipudi V; Zhang J; Lee KC; Cartwright CA
    Mol Cell Biol; 2004 Aug; 24(15):6788-98. PubMed ID: 15254245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth defects induced by perturbation of beta1-integrin function in the mammary gland epithelium result from a lack of MAPK activation via the Shc and Akt pathways.
    Faraldo MM; Deugnier MA; Thiery JP; Glukhova MA
    EMBO Rep; 2001 May; 2(5):431-7. PubMed ID: 11375936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts.
    Chen CC; Chen N; Lau LF
    J Biol Chem; 2001 Mar; 276(13):10443-52. PubMed ID: 11120741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
    Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS
    Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.